MAP2K7 and colorectal carcinoma: Our results showed that treatment with MEK inhibitor increased the mRNA expression of LGR4 in human BRAFV600E-mutant CRC HT29 cells (Figure 5F) and BC mice (Figure 5G), uncovering a negative association between the level of ERK phosphorylation and mRNA expression of Lgr4.